Antiretroviral Activity of the Anti‐CD4 Monoclonal Antibody TNX‐355 in Patients Infected with HIV Type 1

Open Access
Publisher Website
Google Scholar
Abstract
BackgroundWe wished to determine the safety and anti–human immunodeficiency virus (HIV) type 1 activity of single doses of TNX-355, a humanized IgG4